952 results on '"Brock, Gerald"'
Search Results
102. EVALUATION OF THE EFFICACY AND HISTOLOGIC CHANGES OF REPEATED INTRALESIONAL VERAPAMIL INJECTIONS IN AND TRACTION THERAPY IN AN ANIMAL MODEL OF PEYRONIEʼS DISEASE: 1693
103. A NOVEL PEYRONIEʼS DISEASE ANIMAL MODEL COMPARATIVE STUDY OF INTRALESIONAL VERAPAMIL VERSUS NORMAL SALINE INJECTION: ASSESSMENT OF IMMUNOHISTOCHEMICAL OUTCOMES: S4-04
104. SEXUAL DYSFUNCTION IN 2011: Advances in epidemiology, pathophysiology and treatment
105. Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: Opening windows to enhanced sexual function and overall health
106. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study
107. Single perineal incision for artificial urinary sphincter: analysis of technique, outcomes, and experience
108. Men’s health in Canada: A national survey of urologists
109. Clinical pearls to managing men’s health conditions during the COVID-19 pandemic
110. PROTEIN BIOMARKER ANALYSIS OF PRIMARY PEYRONIEʼS DISEASE CELLS: 1077
111. ORIGINAL RESEARCH—COUPLES’ SEXUAL DYSFUNCTIONS: Women's Sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Trial
112. Improving the Sexual Quality of Life of Couples Affected by Erectile Dysfunction: A Double‐Blind, Randomized, Placebo‐Controlled Trial of Vardenafil
113. Efficacy and Safety of Oral Tadalafil in the Treatment of Men in Canada with Erectile Dysfunction: A Randomized, Double‐Blind, Parallel, Placebo‐Controlled Clinical Trial
114. Fractured Penis: Diagnosis and Management (CME)
115. Canadian Male Sexual Health Council Survey to Assess Prevalence and Treatment of Premature Ejaculation in Canada
116. Centers of excellence for penile prosthesis: yes or no?
117. IMPROVEMENTS IN SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA AND RELATED QUALITY OF LIFE FOR MEN WITH OR WITHOUT ERECTILE DYSFUNCTION TREATED WITH ONCE DAILY TADALAFIL: 1925
118. Clinical Case: 45-Year-Old Male with Penile Pain (CME)
119. Current Literature Review
120. Arteriogenic Erectile Dysfunction Alters Protein Expression within the Cavernosal Tissue in an Animal Model
121. MUSE and Intracavernosal Therapies
122. Penile and systemic endothelial function in men with and without erectile dysfunction
123. Effect of nightly vs. on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy
124. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomized controlled trial
125. Phalloplasty: A valuable treatment for males with penile insufficiency
126. Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: Efficacy at 8 and 12 hours postdose
127. Is Vardenafil “Noninferior” or Superior to Sildenafil in the Management of Erectile Dysfunction? Revisiting the Biochemical, Physiological, and Clinical Evidence
128. IMPROVEMENT IN SEXUAL SATISFACTION OF FEMALE PARTNERS OF MEN WITH PREMATURE EJACULATION (PE) TREATED WITH DAPOXETINE (DPX): 1258
129. ENDOTHELIAL EFFECTS OF CHRONIC SILDENAFIL USE AMONG DIABETIC MEN: 1248
130. INTRACORPORAL PRESSURE MEASUREMENT AS AN INDEX OF ERECTILE FUNCTION: IS THERE A BETTER WAY?: 811
131. The Second Information Revolution
132. Priapism: Reasons for Failure by Frank Hinman Jr
133. Can an Educational Program Optimize PDE5i Therapy? A Study of Canadian Primary Care Practices
134. Salvage strategies for nonresponders to phosphodiesterase-5 inhibitor treatment for erectile dysfunction in the aging male
135. Canadian Society for the Study of the Aging Male: Response to Health Canadaʼs Position Paper on Testosterone Treatment
136. The Treatment of Erectile Dysfunction study: focus on treatment satisfaction of patients and partners
137. Case 1: The Patient with ED and Multiple Co-morbidities
138. Case 2: The Patient with Hypogonadism and Multiple Co-morbidities
139. Nonpalpable Scarring of the Penile Septum As a Cause of Erectile Dysfunction: An Atypical Form of Peyronieʼs Disease
140. Bicycling: Is it an independent risk factor for erectile dysfunction?
141. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian ‘Treatment of Erectile Dysfunction’ observational study
142. Obesity, Dyslipidemias and Erectile Dysfunction: A Report of a Subcommittee of the Sexual Medicine Society of North America
143. Contemporary intracavernous pharmacotherapy for erectile dysfunction in the aging male
144. Drug-Induced Male Sexual Dysfunction: An Update
145. Womenʼs Sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
146. Tadalafil: a clinical update
147. Pharmacotherapy for Erectile Dysfunction
148. Interconnection policy and technological progress.
149. Who should be treating erectile dysfunction?
150. GUIDELINES FOR THE SURVEILLANCE OF LOCALIZED RENAL CELL CARCINOMA BASED ON THE PATTERNS OF RELAPSE AFTER NEPHRECTOMY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.